Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

Developing a Health Literacy and Clear Communications e-Course AGENDA 6:00 am Pre-conference Yoga Class Tim Tokarski, MHA, MBA, Director 7:00 am Registration Open, Networking Breakfast in the Resource Center 8:30 am Welcome & Introductions Barbara McAneny, MD, President, NMSCO 8:35 am H&N Current Landscape: A Didactic Presentation Moises Harari Turquie, MD, UNM Health Services …
Survey-Patient-Satisfaction-Multicare-Regional-Cancer-Center
Kootenai-Clinic-Cancer-Services-Oral-Chemotherapy-Checklist
KentuckyOne-Lung-Cancer-Screening-Risk-Benefit-Information-for-Patients-2016
25-KentuckyOne-Lung-Screening-Risks&BenefitsInformation-for-Patients
Innovations should advance the goals of improving access, quality, and value in cancer care delivery. Applicants should fully explain how their program achieves these goals, and how it can be replicated in other cancer programs. Potential focus areas include telehealth and virtual care; staffing models; cancer service line sustainability; care coordination; patient-centered care and supportive …
PowerPoint Presentation Medicare Updates Shane Mull, MD, MHA, FAAFP, CPC Senior Medical Director Palmetto GBA February 17, 2023 Presenter Notes Presentation Notes Shane Mull, MD, has no relevant financial relationships to disclose. Disclosure of Conflicts of Interest 2 Shane Mull, MD Senior Medical Director Shane.Mull@palmettogba.com …
MULTIDISCIPLINARY CUTANEOUS SQUAMOUS CELL CARCINOMA CARE MULTIDISCIPLINARY CUTANEOUS SQUAMOUS CELL CARCINOMA CARE Missouri Oncology Society Spring Conference Friday, May 10 Teledermatology: More than Skin Deep Speakers Emily Smith, MD Assistant Professor, Clinical Dermatology and Dermapathology University of Missouri, Ellis Fischel Cancer Center …
Assessing the Status of Biomarker Testing in Metastatic Colorectal Cancer and the Challenges Faced by Community Cancer Care Teams Summary of Survey Findings February 2021 2 In January 2021, the Association of Community Cancer Centers (ACCC) surveyed 111 community oncology practitioners around the U.S. to assess the status of …
Dear Healthcare Professional, We are writing to inform you that on June 29, 2020, the Food and Drug Administration (FDA) approved PHESGO™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf) injection, for subcutaneous use. PHESGO is a fixed-dose combination of pertuzumab and trastuzumab, HER2/neu receptor antagonists, and hyaluronidase, an endoglycosidase.1 Indications Early Breast Cancer …
Data Entry Sheet Subject Instrument: Demographic and Clinical Features Sex Race Primary Insurance Type Aggregate Clinical Stage NSCLC Histology Instrument: Molecular Testing Did the clinician request Molecular Testing for this patient? (tissue testing, not including PDL1) Did this patient receive Molecular Testing? (tissue testing, not including PDL1) If Yes, was it a single …
PowerPoint Presentation Eliminating Disparities in Access to Quality Care in Patients With Gastric and Esophagogastric Junction Adenocarcinoma Tom Dragovich MD, PhD Tonya J. Kinsinger, MSN, RN, AGNP-C, OCN Banner MD Anderson Cancer Center DISCLOSURES: • Tomislav Dragovich has no financial relationships with commercial interests • Tonya J. Kinsinger has no financial …
Slide 1 accc-iclio.org accc-iclio.org Immunotherapy in Melanoma: Use in Patients with Autoimmune Diseases Christine M. Walko, PharmD, BCOP, FCCP Personalized Medicine Specialist Chair, Clinical Genomic Action Committee Moffitt Cancer Center, Tampa, FL accc-iclio.org Review the current place in practice for immunotherapy in melanoma Discuss the use of immunotherapy in patients …
Slide 1 accc-iclio.org accc-iclio.org Immunotherapy in Melanoma: Use in Patients with Autoimmune Diseases Christine M. Walko, PharmD, BCOP, FCCP Personalized Medicine Specialist Chair, Clinical Genomic Action Committee Moffitt Cancer Center, Tampa, FL accc-iclio.org Review the current place in practice for immunotherapy in melanoma Discuss the use of immunotherapy in patients …
QUESTIONS? Registration: btregistration@spargoinc.com Hotel Reservation: bthousing@spargoinc.com Phone: 888-788-1522 (within the U.S.) or +1-703-449-6418 (outside the U.S.) Hours of Operation: 8:30 AM–5:00 PM (ET) REGISTRATION AND HOTEL RESERVATIONS asco.org/btregister HOTEL RESERVATION AND EARLY REGISTRATION DEADLINE June 28, 2023, at 11:59 PM (ET) Am er ic an …
CPG-Appendix
2021 ACCC Treasurer’s Report Nadine J. Barrett, PhD, MA, MS The statement of Financial Position shows an increase in net assets of $5,076,393 from $10,542,614 to $15,619,007 for fiscal year 2020–2021. The increase is largely due to funding for new educational programming. The Statement of Activities and Change in Net Assets shows total unrestricted net assets at year-end of $94,195, down …
FAN-Patient-Financial-Advocate
(continued) May 7, 2019 To: Valued Customer PRODUCT APPROVAL NOTICE TABRECTA Novartis Pharmaceuticals Corporation announces that TABRECTA™ (capmatinib) tablets was approved by the US Food and Drug Administration on May 6, 2020. Indication TABRECTA is indicated for the treatment of adult patients with metastatic non-small cell lung …
PowerPoint Presentation MULTIDISCIPLINARY MULTIPLE MYELOMA CARE Regional Lecture Series Leveraging a Multidisciplinary Approach to Multiple Myeloma Care Leveraging a Multidisciplinary Approach to Multiple Myeloma Care Abhinav B. Chandra, MD, MSc, FACP Medical Director Yuma Regional Medical Center Cancer Center Learning Objectives I. Discuss ways to tailor …